Russell Investments Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5K | Sell |
1,335
-7,016
| -84% | -$65.8K | ﹤0.01% | 3287 |
|
|
2025
Q1 | $59.4K | Sell |
8,351
-109,064
| -93% | -$775K | ﹤0.01% | 2869 |
|
|
2024
Q4 | $1.37M | Sell |
117,415
-81,095
| -41% | -$946K | ﹤0.01% | 1850 |
|
|
2024
Q3 | $4.08M | Buy |
198,510
+47,932
| +32% | +$985K | 0.01% | 1293 |
|
|
2024
Q2 | $3.37M | Buy |
150,578
+40,335
| +37% | +$903K | 0.01% | 1356 |
|
|
2024
Q1 | $3.03M | Sell |
110,243
-961
| -0.9% | -$26.4K | ﹤0.01% | 1420 |
|
|
2023
Q4 | $3.39M | Sell |
111,204
-16,063
| -13% | -$490K | 0.01% | 1323 |
|
|
2023
Q3 | $4.02M | Buy |
127,267
+27,730
| +28% | +$877K | 0.01% | 1189 |
|
|
2023
Q2 | $4.06M | Sell |
99,537
-10,829
| -10% | -$442K | 0.01% | 1185 |
|
|
2023
Q1 | $4.11M | Buy |
110,366
+33,968
| +44% | +$1.27M | 0.01% | 1193 |
|
|
2022
Q4 | $2.67M | Sell |
76,398
-5,969
| -7% | -$208K | 0.01% | 1412 |
|
|
2022
Q3 | $4.61M | Sell |
82,367
-31,359
| -28% | -$1.75M | 0.01% | 1093 |
|
|
2022
Q2 | $5.89M | Buy |
113,726
+2,306
| +2% | +$119K | 0.01% | 1020 |
|
|
2022
Q1 | $8.1M | Buy |
111,420
+34,526
| +45% | +$2.51M | 0.01% | 919 |
|
|
2021
Q4 | $9.09M | Buy |
76,894
+43,763
| +132% | +$5.17M | 0.01% | 945 |
|
|
2021
Q3 | $4.44M | Buy |
33,131
+5,134
| +18% | +$688K | 0.01% | 1322 |
|
|
2021
Q2 | $4.53M | Sell |
27,997
-25,520
| -48% | -$4.13M | 0.01% | 1416 |
|
|
2021
Q1 | $4.29M | Sell |
53,517
-34,056
| -39% | -$2.73M | 0.01% | 1435 |
|
|
2020
Q4 | $4.77M | Buy |
+87,573
| New | +$4.77M | 0.01% | 1258 |
|
|
2017
Q2 | – | Sell |
-9,698
| Closed | -$137K | – | 3010 |
|
|
2017
Q1 | $137K | Buy |
+9,698
| New | +$137K | ﹤0.01% | 2777 |
|